HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetic Ingredient Innovation In An Increasingly Cruelty-Free World; Is It Possible?

This article was originally published in The Rose Sheet

Executive Summary

Visibility is low into the availability of new cosmetic ingredients since 2013, but there does appear to be a viable pathway for innovations to reach the EU market, despite the animal testing ban, as well as California, where similar prohibitions will go into effect in 2020. Still, industry’s best bet is to continue investing in alternative methods development and promoting their acceptance with regulators.

You may also be interested in...



What Now? US Cosmetic Review Has Evaluated Up To 91% Of Ingredients Used Nationwide

CIR’s work is far from done, says executive director Bart Heldreth, citing the cosmetics industry's vibrant innovation tradition and ingredient re-review needs that should keep the program sufficiently busy.

Unilever Compass Points To LGBTQI+, Animals, Earth

Unilever aims to be “the leader in sustainable business globally” under its sustainability Compass unveiled in May 2020. One year later, the firm announces a series of measures benefiting people, animals and planet.

Cruelty Free Europe Grieves: ‘Very Little Left Now’ Of Cosmetic Animal-Testing Bans

The European Chemicals Agency's Board of Appeal finds that REACH requires ingredient registrants to perform animal studies, even if their substances are used exclusively in cosmetic products. Historically opposed industry and animal welfare groups both may lose under the board’s decisions.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS122394

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel